Antibodies (Jun 2024)

Screening for TORCH Antibodies in Croatian Childbearing-Aged Women, 2014–2023

  • Tatjana Vilibic-Cavlek,
  • Branko Kolaric,
  • Marko Belamaric,
  • Mario Sviben,
  • Thomas Ferenc,
  • Dan Navolan,
  • Viktor Bekic,
  • Ljiljana Milasincic,
  • Ljiljana Antolasic,
  • Maja Vilibic,
  • Mateja Vujica Ferenc,
  • Ema Reicher,
  • Tadej Jezek,
  • Ioana Ciohat,
  • Raluca Catalina Parvanescu,
  • Matea Kos,
  • Maja Bogdanic

DOI
https://doi.org/10.3390/antib13020049
Journal volume & issue
Vol. 13, no. 2
p. 49

Abstract

Read online

TORCH infections usually result in mild maternal morbidity, but may cause severe congenital abnormalities. Therefore, it is important to detect maternal infections, monitor the fetus after the disease has been recognized, and define the seronegative women who are at risk of primary infection during pregnancy. From 2014 to 2023, serum samples from 1032 childbearing-aged and pregnant women (16–45 years) were tested for IgM/IgG antibodies to the most common TORCH pathogens: Toxoplasma gondii, rubella virus (RUBV), cytomegalovirus (CMV), and herpes simplex viruses (HSV-1 and HSV-2). The overall IgG seroprevalence rates were 20.1% for T. gondii, 91.3% for RUBV, 70.5% for CMV, 66.8% for HSV-1, and 3.5% for HSV-2. Only HSV-2 seroprevalence was age-related, with a significant progressive increase in seropositivity from 0% in those aged less than 26 years to 9.3% in those older than 40 years. The seroprevalence of T. gondii was higher in residents of suburban/rural areas than in residents of urban areas (27.4% vs. 17.1%). In addition, participants from continental regions were more often toxoplasma-seropositive than those from coastal regions (22.2% vs. 15.3%). HSV-1 seroprevalence was also higher in suburban/rural areas (71.7% vs. 64.7%). Obstetric history was not associated with TORCH seropositivity. Univariate and multivariate risk analysis showed that suburban/rural areas of residence and continental geographic regions were significant risk factors for T. gondii seroprevalence. Furthermore, suburban/rural area of residence was a significant risk factor for HSV-1 seroprevalence, while older age was a significant risk factor for HSV-2 seroprevalence. A declining trend in the seroprevalence of all TORCH pathogens was observed compared to previous Croatian studies (2005–2011). Similarly, the proportion of women simultaneously IgG-seropositive to two or three pathogens decreased over time. The maternal serology before pregnancy could potentially reduce the burden of congenital TORCH infections.

Keywords